Arno Trading Est. Pharmaceutical Import Profile — Jordan (DGFT 2022–2026)

Name: Arno Trading Est. Pharmaceutical Import Records from India — 2 Products, $67.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Arno Trading Est. — Pharmaceutical Importer Profile (2026) | 2 Products, $67.1K Trade | TransData Nexus

Arno Trading Est.

Pharmaceutical Importer · Jordan · Advanced Oncology Focus · $67.1K Total Trade · DGFT Verified

Arno Trading Est. is a pharmaceutical importer based in Jordan with a total trade value of $67.1K across 2 products in 1 therapeutic categories. Based on 6 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Arno Trading Est. sources from 2 verified Indian suppliers, with Neon Laboratories Limited accounting for 56.3% of imports.

Arno Trading Est. — Import Portfolio & Supplier Network

Arno Trading Est. import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Arno Trading Est.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Neon Laboratories Limited	$143.2K	9	56.3%
Panacea Biotec Pharma Limited	$111.2K	3	43.7%

Arno Trading Est. sources from 2 verified Indian suppliers across .

What Formulations Does Arno Trading Est. Import?

Formulation	Value	Ships
Bemustin injection (bendamustine	$71.6K	2
Dacarbazine for injection USP (lyophilised) 100MG/vial-zicarb	$40.3K	2
Vagacyte (valganciclovir tablets USP	$39.5K	1
Anawin heavy bupivacaine hydrochloride	$36.8K	1
Thiosol thiopental sodium for	$36.0K	1
Zicarb 200 dacarbazine for injection	$10.0K	1
Zicarb 100 dacarbazine for injection	$9.0K	1
Mitoxantrone injection USP 20 MG/10	$7.9K	2
Nitrol mitoxantrone injection USP	$3.3K	1

Arno Trading Est. imports 9 distinct pharmaceutical formulations. Showing top 9 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Dacarbazine	Advanced Oncology	$59.3K	4	2.8%	6
2	Mitoxantrone	Advanced Oncology	$7.9K	2	0.4%	7

Arno Trading Est. imports 2 pharmaceutical products across 1 categories into Jordan totaling $67.1K.

Arno Trading Est. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Arno Trading Est. is a pharmaceutical importer based in Amman, Jordan, specializing in the procurement of finished pharmaceutical formulations. The company operates as a buyer, sourcing medications primarily from India, and plays a significant role in the distribution of oncology treatments within the Jordanian market. While specific details about its parent company are not publicly available, Arno Trading Est. is recognized for its focus on high-quality pharmaceutical products, particularly in the oncology therapeutic category.

2Distribution Network

Arno Trading Est. maintains a centralized distribution hub in Amman, strategically located to facilitate efficient logistics and supply chain operations across Jordan. The company's logistics capabilities are tailored to handle the importation and distribution of pharmaceutical products, ensuring timely delivery to various healthcare facilities and pharmacies nationwide. While the primary focus is on the domestic market, there is no publicly available information indicating significant distribution activities beyond Jordan.

3Industry Role

In Jordan's pharmaceutical supply chain, Arno Trading Est. functions as a primary wholesaler and importer, specializing in the acquisition and distribution of finished pharmaceutical formulations. The company's emphasis on oncology products positions it as a key supplier of specialized medications, catering to the needs of hospitals, clinics, and pharmacies that require these treatments. Arno Trading Est. does not appear to engage in parallel importing or act as a logistics intermediary, focusing instead on direct procurement and distribution.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Arno Trading Est.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Arno Trading Est. demonstrates a high degree of supplier concentration, sourcing its pharmaceutical products exclusively from two Indian manufacturers: Neon Laboratories Limited and Panacea Biotec Pharma Limited. This sourcing strategy results in a portfolio concentration where the top two products—Dacarbazine and Mitoxantrone—account for 100% of the company's imports. While this approach may streamline procurement processes and foster strong supplier relationships, it also exposes the company to risks associated with over-reliance on a limited number of suppliers. Any disruptions in the supply chain from these manufacturers could significantly impact Arno Trading Est.'s ability to meet market demand.

2Supply Chain Resilience

The resilience of Arno Trading Est.'s supply chain is closely tied to the stability and reliability of its Indian suppliers. The company's exclusive sourcing from Neon Laboratories Limited and Panacea Biotec Pharma Limited suggests a deep integration and reliance on these suppliers. However, the lack of publicly available information regarding backup suppliers or alternative sourcing strategies indicates potential vulnerabilities. Additionally, the company's focus on a narrow range of formulations within the oncology category may limit its ability to adapt to changes in market demand or supply chain disruptions.

Importing Pharmaceuticals into Jordan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Jordan

1Regulatory Authority & Framework

The Jordan Food and Drug Administration (JFDA) is the primary regulatory body overseeing the pharmaceutical sector in Jordan. The JFDA is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products through stringent regulations and oversight. Key legislation governing pharmaceutical imports includes the Pharmaceutical Establishments Licensing Regulation No. 162 of 2019, which outlines the requirements for establishing and operating pharmaceutical establishments in Jordan. This regulation mandates that all pharmaceutical products, including those imported, must be registered with the JFDA before they can be marketed or distributed within the country.

2Import Licensing & GMP

Importers of pharmaceutical products in Jordan are required to obtain an importer's card from the Ministry of Industry, Trade, and Supply. This card is essential for customs clearance and is typically issued to registered traders or commercial entities. Additionally, pharmaceutical establishments must adhere to Good Manufacturing Practice (GMP) standards recognized by the JFDA. While the JFDA may consider GMP certifications from reputable international bodies, such as the European Medicines Agency (EMA) or the World Health Organization (WHO), the specific recognition of these certifications is subject to the JFDA's evaluation and approval processes.

Arno Trading Est. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Arno Trading Est.'s focus on importing oncology medications, specifically Dacarbazine and Mitoxantrone, aligns with the growing demand for cancer treatments in Jordan. The company's strategy to concentrate on these high-demand products allows it to establish a strong presence in the oncology segment, catering to the needs of healthcare providers and patients seeking specialized treatments. This targeted approach enables Arno Trading Est. to leverage its expertise and build robust relationships with suppliers and customers within the oncology therapeutic area.

2Sourcing Profile

Arno Trading Est. employs a sourcing strategy that emphasizes the procurement of generic oncology drugs from India, focusing on finished pharmaceutical formulations. This approach allows the company to offer cost-effective treatment options while maintaining quality standards. India's well-established pharmaceutical manufacturing sector, known for its adherence to international GMP standards, makes it a reliable source for these products. By concentrating on a narrow range of formulations, Arno Trading Est. aims to streamline its operations and ensure a consistent supply of critical oncology medications.

3Market Positioning

Seller's Guide — How to Become a Supplier to Arno Trading Est.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter Arno Trading Est.'s supply chain by offering alternative formulations or additional oncology medications that complement the existing product line. By diversifying the range of products available, suppliers can help Arno Trading Est. meet a broader spectrum of market demands and reduce its dependency on a limited number of products. Additionally, suppliers that can provide innovative formulations or improved delivery methods may find a receptive partner in Arno Trading Est., which is committed to enhancing the quality and effectiveness of cancer treatments available in Jordan.

2Requirements & Qualifications

Indian exporters seeking to supply Arno Trading Est. must ensure that their products are registered with the JFDA and comply with the regulatory standards set forth by the agency. This includes obtaining necessary approvals, adhering to GMP standards recognized by the JFDA, and ensuring that all labeling and packaging meet the requirements for the Jordanian market. Additionally, exporters should be prepared to provide documentation such as certificates of origin, stability data, and any other information required by the JFDA to facilitate the importation process.

How to Approach

Frequently Asked Questions — Arno Trading Est.

What products does Arno Trading Est. import from India?

Arno Trading Est. imports 2 pharmaceutical products across 1 categories. Top imports: Dacarbazine ($59.3K), Mitoxantrone ($7.9K).

Who supplies pharmaceuticals to Arno Trading Est. from India?

Arno Trading Est. sources from 2 verified Indian suppliers. The primary supplier is Neon Laboratories Limited (56.3% of imports, $143.2K).

What is Arno Trading Est.'s total pharmaceutical import value?

Arno Trading Est.'s total pharmaceutical import value from India is $67.1K, based on 6 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Arno Trading Est. focus on?

Arno Trading Est. imports across 1 categories. The largest: Advanced Oncology (100.0%).

Get Full Arno Trading Est. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.